Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2004 6(4):274-280; DOI:10.1215/S1152851704000109
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, D. A.
Right arrow Articles by Inskip, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Epidemiology and Cancer Control

Meningioma and schwannoma risk in adults in relation to family history of cancer

Deirdre A. Hill1, Martha S. Linet, Peter M. Black, Howard A. Fine, Robert G. Selker, William R. Shapiro and Peter D. Inskip

Division of Cancer Epidemiology and Genetics (D.A.H., M.S.L., P.D.I.) and Neuro-Oncology Branch (H.A.F.), National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA 02115 (P.M.B.); Division of Neurosurgery, Western Pennsylvania Hospital, Pittsburgh, PA 15224 (R.G.S.); and Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013 (W.R.S.); USA

1 Address correspondence to Deirdre A. Hill, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7238 N, Bethesda, MD 20892-7238 (dhill{at}mail.nih.gov).

Abstract

Relatively little is known about factors that contribute to the development of meningioma and vestibular schwannoma, two intracranial nervous system tumors. We evaluated the risk of these tumors in relation to family history of malignant or benign tumors. Incident cases of meningioma (n = 197) or schwannoma (n = 96) were identified at three U.S. referral hospitals between June 1994 and August 1998. Controls (n = 799) admitted to the same hospitals for nonmalignant conditions were matched to cases on age, sex, race/ethnicity, hospital, and proximity of residence to hospital. We found that risk of meningioma was increased among persons reporting a family history of a benign brain tumor (odds ratio [OR], 4.5; 95% confidence interval [CI], 1.0–21.0; n = 5) or melanoma (OR, 4.2; 95% CI, 1.2–15.0; n = 5). A family history of breast cancer was associated with an elevated meningioma risk among participants aged 18 to 49 years (OR, 3.9; 95% CI, 1.4–11.0; n = 8) but a reduced risk among older respondents (OR, 0.2; 95% CI, 0.1–0.7; n = 3). Family history of cancer did not differ between schwannoma cases and controls, although the statistical power to detect associations was limited. Some relative risk estimates were based on a small number of observations and may have arisen by chance. Inheritance of predisposing genes, shared environmental factors, or both within families with a history of benign brain tumors, melanoma, or possibly breast cancer may be related to altered meningioma risk.







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2004 by Society for Neuro-Oncology